Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients

被引:9
|
作者
Ruiz-Idiago, Jesus [1 ,2 ,3 ,4 ,6 ]
Pomarol-Clotet, Edith [4 ,5 ]
Salvador, Raymond [4 ,5 ]
机构
[1] Hermanas Hosp, Hosp Mare Deu Merce, Neuropsychiat Unit, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain
[3] European Huntingtons Dis Network EHDN, Ulm, Germany
[4] FIDMAG Germanes Hospitalaries Res Fdn, Barcelona, Spain
[5] Mental Hlth Res Networking Ctr CIBERSAM, Madrid, Spain
[6] Neuropsychiat Unit, Avda Jorda 10, Barcelona 08035, Spain
关键词
Huntington?s disease; Neuropsychiatric symptoms; Longitudinal studies; Apathy; Irritability; Perseveration; PROBLEM BEHAVIORS ASSESSMENT; FUNCTIONAL DECLINE; SUICIDAL IDEATION; PBA-S; RELIABILITY;
D O I
10.1016/j.parkreldis.2022.11.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The relationship between neuropsychiatric symptoms (NPS) and other clinical dimensions in Huntington's disease (HD) is controversial. This longitudinal study analyzed the association between NPS and motor, cognitive and functional aspects of the disease along with other variables related to its clinical onset and progression.Methods: 639 early-moderate HD patients were assessed longitudinally (mean: 4.95 visits/5 years). Generalized linear mixed models were used to explore associations between NPS and the aforementioned aspects. Other variables previously reported as significant in smaller or cross-sectional studies were included in the models.Results: Significant associations found included a negative linear relationship between presence of depressed mood and illness duration (7.2% odds reduction of being depressed per year), a 7.6% increase in the odds of having irritability with increased chorea scores, a negative association (4.3% reduction in odds) between age at onset and aggression (i.e. earlier onset was related to a higher probability of having aggressive behaviors) and a negative association between irritability and the interference component of the Stroop test (3% odds change). Total functional capacity (TFC) was the most frequently associated factor with NPS, with apathy and persev-erative behavior having the strongest relations with TFC (22% and 18% increases in odds per unit reduction in TFC respectively).Conclusions: With the exception of irritability, NPS are not related to motor or cognitive variables in early -moderate HD. Total functional capacity (TFC) is the most frequently associated factor with NPS, with apathy and perseverative behavior having the strongest relations with TFC.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Striatal hypometabolism in premanifest and manifest Huntington’s disease patients
    Diego Alfonso López-Mora
    Valle Camacho
    Jesús Pérez-Pérez
    Saül Martínez-Horta
    Alejandro Fernández
    Frederic Sampedro
    Alberto Montes
    Gloria Andrea Lozano-Martínez
    Beatriz Gómez-Anson
    Jaime Kulisevsky
    Ignasi Carrió
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2183 - 2189
  • [32] Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
    Wang, Rui
    Ross, Christopher A.
    Cai, Huan
    Cong, Wei-Na
    Daimon, Caitlin M.
    Carlson, Olga D.
    Egan, Josephine M.
    Siddiqui, Sana
    Maudsley, Stuart
    Martin, Bronwen
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [33] Visual Object Perception in Premanifest and Early Manifest Huntington's Disease
    Coppen, Emma M.
    Jacobs, Milou
    van der Zwaan, Kasper F.
    Middelkoop, Huub A. M.
    Roos, Raymund A. C.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2019, 34 (08) : 1320 - 1328
  • [34] White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis
    Sweidan, Wafaa
    Bao, Fen
    Bozorgzad, Navid-Seraji
    George, Edwin
    JOURNAL OF NEUROIMAGING, 2020, 30 (03) : 351 - 358
  • [35] The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington's Disease from China: A Cross-Sectional Study
    Cheng, Yangfan
    Gu, Xiaojing
    Liu, Kuncheng
    Yang, Tianmi
    Xiao, Yi
    Jiang, Qirui
    Huang, Jingxuan
    Lin, Junyu
    Wei, Qianqian
    Ou, Ruwei
    Hou, Yanbing
    Zhang, Lingyu
    Li, Chunyu
    Burgunder, Jean-Marc
    Shang, Huifang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [36] Moderate hyperhomocysteinemia in patients with Huntington's disease
    Laich, A
    Leblhuber, F
    Widner, B
    Frick, B
    Jellinger, K
    Fuchs, D
    PTERIDINES, 2002, 13 (04) : 121 - 125
  • [37] Prevalence of Neurocognitive Disorder in a Pre-manifest Huntington's disease Cohort
    Sierra, Luis
    Ullman, Clementina
    Baselga-Garriga, Clara
    Hildebrand, Karen
    Frank, Samuel
    Laganiere, Simon
    NEUROLOGY, 2023, 100 (17)
  • [38] Intermediate CAG repeats in Huntington's disease. A longitudinal analysis of the European Huntington's Disease Network REGISTRY Cohort
    Cubo, Esther
    Antonia Ramos-Arroyo, Maria
    Martinez-Horta, Saui
    Martinez-Descalis, Asuncion
    Gii-Poio, Cecilia
    NEUROLOGY, 2016, 86
  • [39] Olfaction and neuropsychiatric symptoms in early Parkinson's disease
    Choi, J. K.
    Hong, J. Y.
    Sunwoo, M. K.
    Ham, J. H.
    Lee, J. J.
    Lee, P. H.
    Sohn, Y. H.
    MOVEMENT DISORDERS, 2015, 30 : S152 - S152
  • [40] Early Signs and Neuropsychiatric Symptoms in Parkinson's Disease
    Kasten, Meike
    Vollstedt, Eva-Juliane
    Klein, Christine
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2014, 25 (01) : 31 - 38